Two-drug immunotherapy deemed safe for lung cancer patients, study shows

Posted by on June 2, 2016 12:32 pm
Categories: health

Utilizing the immunotherapeutic agents nivolumab and ipilimumab could lead to more effective treatment options for non-small cell lung cancer patients who fail initial therapy, report scientists.

Leave a Reply

Your email address will not be published. Required fields are marked *